Longitudinal Analysis of Erythrocytic Molecular Changes and Cardiovascular Risk in Diabetes

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  Diabetes  https://doi.org/10.2337/db25-0463 
Dr. Eftychia Kontidou  et al.

Points

Research demonstrates that red blood cells from type 2 diabetes patients only begin to impair blood vessel function significantly after the disease has been present for seven years or more.
The harmful vascular effects observed in chronic diabetes are directly linked to the downregulation of miR-210-3p within erythrocytes which significantly increases oxidative stress and reduces endothelial dependent relaxation in vessels.
A longitudinal study of newly diagnosed patients revealed that their red blood cells developed these deleterious properties over a seven year period while cells from healthy subjects remained entirely benign.
Experimental restoration of miR-210-3p levels using molecular mimics successfully rescued blood vessel function which suggests that this specific microRNA could serve as a vital therapeutic target for preventing diabetic complications.
Utilizing miR-210-3p as a biomarker allows clinicians to identify patients at high risk of cardiovascular damage before irreversible injury occurs which facilitates much earlier and more effective preventative medical interventions.

Summary

This study investigated the temporal impact of type 2 diabetes on red blood cell (RBC)-mediated endothelial dysfunction. Researchers utilized db/db mice across three developmental stages—7, 14, and 22 weeks—alongside human cohorts categorized into newly diagnosed patients (<1 year duration) and those with long-standing disease (≥7 years duration). The primary objective was to determine how disease progression influences endothelial-dependent relaxation (EDR) and to identify the molecular transitions occurring within the erythrocytes that contribute to vascular impairment.

The findings revealed that RBC-induced vascular damage is significantly time-dependent. In the murine models, RBCs from 14- and 22-week-old mice significantly impaired EDR, whereas cells from 7-week-old mice exhibited no such effect. Similarly, human data demonstrated that RBCs from patients with over seven years of disease duration compromised vascular function, a phenomenon not observed in newly diagnosed individuals. Molecular analysis linked this impairment to a downregulation of miR-210-3p, which coincided with increased vascular expression of glycerol-3-phosphate dehydrogenase 2 (GPD2) and the oxidative stress marker 4-hydroxynonenal (4-HNE).

Follow-up assessments of the newly diagnosed cohort confirmed that their RBCs developed harmful properties after a seven-year interval, whereas healthy control cells remained benign. Transfection with a miR-210-3p mimic successfully rescued the EDR impairment in diseased samples, underscoring the microRNA’s pivotal regulatory role. These results suggest that RBC-derived miR-210-3p serves as a critical biomarker for the early detection of cardiovascular risk in diabetic patients, potentially allowing for preventative interventions before significant macrovascular or microvascular damage occurs.

Link to the article: https://diabetesjournals.org/diabetes/article-abstract/doi/10.2337/db25-0463/164232/Long-Duration-of-Type-2-Diabetes-Drives?redirectedFrom=fulltext

References

Kontidou, E., Collado, A., Humoud, R., Manickam, K., Tengbom, J., Jiao, T., Alvarsson, M., Yang, J., Mellbin, L., Mahdi, A., Pernow, J., & Zhou, Z. (2026). Long duration of type 2 diabetes drives erythrocyte-induced vascular endothelial dysfunction: A link to mirna-210-3p. Diabetes, db250463. https://doi.org/10.2337/db25-0463